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Background: The growing elderly population in Taiwan, as in many other countries, has resulted in
increased importance of the metabolic syndrome (MetS). Although it has been reported in different age
groups, the relationship between platelets and MetS remains unknown in geriatric patients.
Patients and Methods:We enrolled 1460 women >65 years old. Women with a known history of diabetes,
hyperlipidemia or hypertension or those taking medication for these conditions were all excluded. The
women were further divided into quartiles arbitrarily according to platelet count (PC) (PC1ePC4, lowest
to highest accordingly).
Results: Among the MetS components, body mass index (BMI), total cholesterol, low-density lipoprotein
cholesterol (LDL-C) and log transformation triglyceride (Log TG) were all signiﬁcantly higher in the PC4
group (p < 0.05), and they were also positively correlated with PC. However, in multiple regression, BMI
became nonsigniﬁcant. Both LDL-C and Log TG were the only two factors that remained positively and
independently correlated with PC. Compared to PC1, all the other three groups had signiﬁcantly higher
odds ratios for having MetS (2.013, 1.473e2.751; 1.486, 1.081e2.042; 1.537, 1.117e2.114; odds ratios and
95% conﬁdence intervals for PC4, PC3 and PC2, respectively).
Conclusion: Elderly women with MetS had higher PC. Among the ﬁve components, TG was positively
correlated with PC. There was a positive correlation between PC and LDL-C but not high-density
lipoprotein cholesterol. The importance of both lipids might be re-evaluated in the future in older
women.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
As early as 1966, the concept of metabolic syndrome (MetS ) was
ﬁrst proposed by Avogaro et al1. However, the formal deﬁnitionwas
not proposed until recently. In 2001, National Cholesterol Education
Program Adult Treatment Panel III (NCEP ATP-III) issued the deﬁ-
nition of MetS. In short, it is mainly composed of hyperglycemia,
central obesity, hypertension and dyslipidemia2. Although there
have beenmany other modiﬁed deﬁnitions proposed since then, byre.
Road, Hsintien, Taipei County
ei).
iwan Society of Geriatric Emergenfar, the ATP-III version is the one that is most commonly used and
discussed3. It should be emphasized that the purpose of deﬁning
MetS was to enable early detection of individuals at high risk for
cardiovascular diseases (CVDs).
Currently, there is evidence to suggest that CVD is fundamen-
tally a disease of inﬂammation and this perception has been sup-
ported by the positive links between inﬂammatory markers and
CVD4. MetS is a key predictor of CVD, therefore, higher levels of
inﬂammatory markers can be seen in patients with MetS2,5. For
example, white blood cell count, considered as one of the inﬂam-
matory makers, was the ﬁrst to be recognized as a risk factor for
myocardial infarction6, and also correlated with MetS2,5,7e9. More
importantly, Jesri et al also have reported that platelet count (PC),
similar to white blood cell count, is higher in MetS patients10.
Although this phenomenon has already been studied in adults10,11,cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Anthropometric and metabolic variables of subjects with or without MetS.
MetS(e) MetS(þ) p
N 960 500
Age (y) 69.6  4.3 69.8  4.4 0.335
BMI (kg/m2) 17.8  2.8 19.3  2.7 0.000
Systolic BP (mmHg) 138  22.0 150  20.9 0.000
Diastolic BP (mmHg) 76  12.0 80  11.7 0.000
FPG (mg/dL) 103.6  29.3 113.1  35.1 0.000
TC (mg/dL) 217.4  39.7 223.6  40.9 0.005
HDL-C (mg/dL) 56.9  14.2 42.3  11.3 0.000
LDL-C (mg/dL) 138.4  35.2 143.9  35.6 0.006
TG (mg/dL) 110.0  46.6 187.5  70.6 0.000
Log TG 2.0  0.16 2.2  0.16 0.000
Hemoglobin (g/dL) 13.0  1.1 13.2  1.2 0.000
WBC count (103/mL) 6.1  1.9 6.7  1.8 0.000
PC (103/mL) 220.8  61.1 232.9  55.6 0.000
Data are shown as mean  standard deviation. BMI ¼ body mass index; BP ¼ blood
pressure; FPG ¼ fasting plasma glucose; HDL-C ¼ high-density lipoprotein choles-
terol; LDL-C, Low-density lipoprotein cholesterol; Log TG, log transformation of
triglyceride; MetS ¼ metabolic syndrome; PC ¼ platelet count; TC ¼ total choles-
terol; WBC ¼ white blood cell.
Y.-L. Chen et al.202this relationship has not been examined in geriatric patients. In
Taiwan, the proportion of aged people is growing, as in other
countries. Early detection of MetS among these patients has
become an important societal issue. In this study, we examined the
correlations between PC and MetS in women aged >65 years.
2. Methods
2.1. Study subjects
In this cross-sectional study, we enrolled women >65 years old
from individuals receiving an annual health examination at the M J
Life Clinic in Taiwan. The M J Life Clinic is a large institute that
carries out health examinations in North, Central and South Taiwan
and China. This study was approved by the Institutional Review
Board of the M J Life Clinic. All participants gave their informed
consent.
Patients with major medical diseases, known diabetics, or those
taking medication for hyperlipidemia, hypertension or diabetes
were all excluded.Wewanted to evaluate the relationships between
PC and MetS more concisely, therefore, we only included individ-
uals with normal platelet levels. In this way, the relationships
between them could be deﬁned more clearly. After the preliminary
screening, there were 1503 women enrolled. We further excluded
one individual with an abnormal PC of 835 (103/mL) and 42 indi-
viduals with other missing data. Finally, 1460 women were
analyzed. In order to evaluate the components of MetS in different
PC level, the women were further divided into quartiles, PC1ePC4,
according to PC from lowest to highest level.
The NCEP ATP III deﬁnition of MetS was used in this study3.
However, according to the study by Lee et al12, we used the criteria
of body mass index (BMI) S 26.4 instead of waist circumference
S 80 cm in Chinese women.
Participants visited the clinic at 08:00 hours after at least 10
hours fasting. Senior nursing staff obtained information about
medical history, lifestyle, alcohol intake, smoking and physical
exercise. A complete physical examination was done and BMI was
calculated as weight/height2 (kg/m2). Formeasuring blood pressure
(BP), the participants were required to rest for at least 5minutes. BP
was measured by nursing staff using standard mercury sphygmo-
manometers on the right arm, with the patient in the seated
position. Blood samples were drawn from the antecubital vein for
biochemistry studies.
2.2. Laboratory measurement
The plasma was separated from the blood within 1 hour of
being drawn, and stored at e30C until analysis. The samples
were analyzed for plasma glucose and lipid levels. Plasma
glucose was measured with a glucose oxidase method (YSI 203
glucose analyzer; Yellow Spring Instrument Company, Yellow
Spring, OH, USA). Triglyceride (TG) and total cholesterol (TC)
were measured with the dry, multilayer analytical slide method
in the Fuji Dri-Chem 3000 analyzer (Fuji Photo Film; Minato-Ku,
Tokyo, Japan). Serum concentration of high-density lipoprotein
cholesterol (HDL-C) and low-density lipoprotein cholesterol
(LDL-C) was measured using an enzymatic cholesterol assay
following dextran sulfate precipitation. PC was measured with an
Abbott Cell Dyn 3000 hematology analyzer (Abbott Laboratories,
Abbott Park, IL, USA).
2.3. Statistical analysis
The data were analyzed with SPSS version 13.0 (SPSS, Chicago,
IL, USA). All data were tested for normal distribution with theKolmogoroveSmirnov test and for homogeneity of variances with
Levene’s test. Continuous variables were expressed as mean 
standard deviation. The t test was used to evaluate the differences
between the two groups.When comparing the differences between
the three groups, one-way analysis of variance was used. For post
hoc comparison, the Bonferroni test was applied. To observe the
correlation between different parameters, simple correlation and
multivariate linear regression were used. Finally, the odds ratio
(OR) was calculated to compare the possibility of having MetS in
different groups. Among all the parameters, TG was not normally
distributed; log transformation (Log TG) was performed before
further analysis. All statistical tests were two-sided and considered
statistically signiﬁcant at p < 0.05.3. Results
Among the 1460 women, 500 had MetS. The anthropometric
variables, BP, blood biochemistry and PC are shown in Table 1. There
was no signiﬁcant difference between age in women with and
without MetS. However, other parameters such as BMI, systolic BP,
diastolic BP, fasting plasma glucose (FPG), TC, HDL-C, LDL-C, Log TG,
hemoglobin, white blood cell count and PC were all signiﬁcantly
higher in the MetS group (p < 0.01).
The MetS components in the four groups of PC1ePC4 are shown
in Table 2. BMI, TC, LDL-C and Log TGwere all signiﬁcantly higher in
the PC4 group (p < 0.05). When simple correlation was used to
examine their relationship, they were also positively correlated
with PC as expected (Table 3). However, when all these components
were analyzed by multiple regression, BMI became nonsigniﬁcant
(Table 4). LDL-C and Log TG were the only two factors that
remained positively and independently correlated with PC.
Compared to PC1, all the other three groups had signiﬁcantly higher
ORs for MetS (2.013, 1.473e2.751; 1.486, 1.081e2.042; 1.537,
1.117e2.114; ORs and 95% conﬁdence intervals for PC4, PC3 and PC2,
respectively; Fig. 1). Finally, to demonstrate further their relation-
ship graphically, Fig. 2 shows that higher PCs were seen when
women had more MetS components. The PCs were 202.6 
59.3  103/mL, 224.8  60.7  103/mL, 221.8  61.3 103/mL,
229.0 55.8 103/mL and 240.8 54.6 103/mL for 0, 1, 2, 3 and>4
MetS components, respectively. This trend reached statistical
signiﬁcance (r ¼ 0.922, p ¼ 0.026). In contrast, Fig. 3 shows the
opposite relationship, that is, the numbers of MetS components in
different PC groups (1.82  1.07, 2.08  1.16, 2.04  1.08 and
Table 2
Components of MetS in patients with different PC.
PC1 PC2 PC3 PC4 p
N 365 359 367 369
PC ( 103 /mL) 155.2  28.52,3,4 203.6  9.41,3,4 238.2  11.41,2,4 301.4  41.81,2,3 0.000
Age (y) 69.9  4.4 70.0  4.5 69.4  4.3 69.4  4.1 0.088
BMI (kg/m2) 17.9  2.91,2,3 8.4  2.8 18.5  2.71,2,3 8.4  2.8 0.024
SBP (mmHg) 140  23.0 143  22.73 143  21.8 141  21.6 0.077
DBP (mmHg) 76  12.01,2,3 77  12.01,2,3 78  11.71,2,3 77  12.12,3 0.079
FPG (mg/dl) 106.1  35.61,2,3 108.1  34.32,3 107.4  29.91,3 105.9  26.51,2,3 0.747
TC (mg/dl) 206.9  37.92,3,4 215.8  38.21,3,4 224.3  39.11,2,3 230.8  41.81,2,3 0.000
HDL-C (mg/dl) 53.0  15.41,2,3 50.3  14.41,2,3 52.3  14.61,2,3 51.9  15.31,2,3 0.097
LDL-C (mg/dl) 130.7  33.62,3,4 138.8  34.41,2,4 143.7  36.01,4 147.9  35.51,2,3 0.000
TG (mg/dl) 116.7  57.92,3,4 133.8  64.01,2,4 141.1  65.51,4 154.2  74.11,2,3 0.000
Log TG 2.02  .1892,3,4 2.08  .1891,2,4 2.11  .1871,2 2.14  .2071,2,3 0.000
Data are shown as mean  standard deviation. BMI ¼ body mass index; DBP ¼ diastolic blood pressure; FPG ¼ fasting plasma glucose; HDL-C ¼ high-density lipoprotein
cholesterol; LDL-C ¼ low-density lipoprotein cholesterol; Log TG ¼ log transformation of triglyceride; MetS ¼metabolic syndrome; PC ¼ platelet count; SBP ¼ systolic blood
pressure; TC ¼ total cholesterol; TG ¼ triglyceride.
Platelet Count in Metabolic Syndrome 2032.23  1.13 for PC1, PC2, PC3 and PC4, respectively). However, the
trend was not signiﬁcant (r ¼ 0.907, p ¼ 0.093).
4. Discussion
The purpose of our study was to investigate the relationships
between PC and components of MetS in geriatric Taiwanese
women. Patients with major medical diseases, known diabetics, or
those taking medication for hyperlipidemia, hypertension or dia-
betics were all excluded. Therefore, our results should be inter-
preted with caution. However, our design ensured that the
relationships that we evaluated between PC and MetS should
become more concisely because we removed all these confounding
factors. It is worth noting that our study is believed to be the ﬁrst in
this ﬁeld. In general, the ﬁndings in this study were similar to
others done in different cohorts10,11. However, therewere still some
novel and interesting results that are worthy of note.
The relationship between PC and adiposity has been reported
previously13e15. The fact that both PC and adiposity are positively
correlated with inﬂammatory markers indicates that inﬂammatory
markers might be the crucial mediators between them. For
example, Yudkin et al have indicated that interleukin (IL)-6 levels
were correlated with adiposity in a group of Caucasians16. IL-6 is
also known to be the main inﬂammatory marker that is correlated
with PC17,18. Our results showed that womenwith higher PC (group
PC4) had higher BMI, which is similar to other studies13e15. This
relationship was conﬁrmed by their signiﬁcant positive Pearson
correlation (Table 3). However, there are twomajor differences that
should be pointed out in our study. First, the BMI was much lower
than in the other three studies, partly because the other study
cohorts were Caucasian and Jews. Second, after adjustment for the
other signiﬁcant parameters (LDL-C and TG) in the multipleTable 3
Simple correlation between PC and each MetS component.
r p
BMI 0.061 0.020
Systolic BP 0.021 0.421
Diastolic BP 0.030 0.258
FPG 0.012 0.657
TC 0.230 0.000
HDL-C 0.003 0.921
LDL-C 0.190 0.000
Log TG 0.185 0.000
BMI ¼ body mass index; BP ¼ blood pressure; FPG ¼ fasting plasma glucose;
HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ low-density lipoprotein
cholesterol; Log TG ¼ log transformation of triglyceride; MetS ¼ metabolic
syndrome; PC ¼ platelet count; TC ¼ total cholesterol.regression, the signiﬁcance between BMI and PC disappeared. This
result indicated that the relationship between BMI and PC was
actually mediated through TG and/or LDL-C. This paradoxical
ﬁnding could be easily explained by the well-documented corre-
lations between adiposity and higher TG and LDL-C19. Thus, we
propose that the elevation of these two lipids might elevate PC in
elderly individuals, rather than BMI itself. Our ﬁnding is not unique
because several other studies have shown that individuals with
either hypertriglyceridemia or high LDL-C have higher platelet
activity20e23. Again, although a more sophisticated method was
used in those studies (platelet activity), their cohorts were small.
Lower HDL-C level, but not high LDL-C level, is considered to be
a component of MetS. In our study, the negative relation between
PC and HDL-C was observed as expected, but it was not statistically
signiﬁcant. On the contrary, both TC and LDL-C were all higher in
the PC4 group, and they were signiﬁcantly positively correlated
with PC. This positive correlation continued even in the multiple
regression after BMI and TG were taken into consideration. Before
trying to ﬁnd the underlying link between LDL-C and PC, it should
be noted that LDL-C level is correlated with both vascular inﬂam-
mation24,25 and platelet activity22,23. The increased platelet reac-
tivity may be due to inhibition of the Naþ/Hþ antiport through
receptor-independent mechanisms26. Also, a low-grade inﬂam-
matory process is associated with PC17,18. Thus, similar to adiposity,
inﬂammation is one possible key connection between PC and LDL-
C. Oda et al also have found that LDL-C is associated with MetS in
Japanese individuals, which supports our ﬁndings indirectly27. The
role of LDL-C in MetS should be re-evaluated in different pop-
ulations in the future.
Our study suggests that TG is the last component of MetS found
to be correlated with PC. If MetS is considered to be a state of low-
grade inﬂammation, then it would be reasonable to ﬁnd this
correlation between TG and PC28,29. Concerning the common
association of low grade inﬂammation, the ﬁrst substantial
evidence came from studies of Clarke et al and Kaser et al17,18. They
have shown that IL-6 is associated with PC by stimulating throm-
bopoiesis with thrombopoietin17,18. Other inﬂammatory markers,Table 4
Multiple regression of PC and MetS components.
r p
BMI 0.005 0.862
LDL-C 0.173 0.000
Log TG 0.189 0.000
BMI ¼ body mass index; LDL-C ¼ low-density lipoprotein cholesterol; Log
TG ¼ log transformation of triglyceride; MetS ¼ metabolic syndrome;
PC ¼ platelet count.
Fig. 1. OR for subjects in different PC groups of having metabolic syndrome. All the
three groups (PC2ePC4) had signiﬁcant odds ratio than PC1. OR ¼ odds ratio;
PC ¼ platelet count.
Fig. 3. PC groups and metabolic syndrome components. PC1ePC4: groups of subjects
with different PCs from the lowest quartile to highest. PC ¼ platelet count.
Y.-L. Chen et al.204especially tumor necrosis factor a, have also been found to be
associated with TG both in vivo and in vitro30,31. These studies
strongly support our ﬁndings. Still, it should be noted that our study
is believed to be the ﬁrst to show this relationship in elderly
women.
We also discovered that there was no positive correlation
between PC and FPG or BP, as expected. Theoretically, a positive
correlation should be found between FPG and BP because it is well
known that they are related to inﬂammation32,33. With regard to PC
and hypertension, there have been few studies that have speciﬁ-
cally focused on the relationship between PC and BP. Indirect
information can be drawn from the study of Spencer et al, which
showed that PC was not increased in patients with hypertension34.
Other studies in this ﬁeld have only examined the relationship
between BP and platelet activity, which is not the same as PC35. Our
study is believed to be the ﬁrst to examine this relationship in
a large cohort of elderly patients. With regard to the relationship
between FPG and PC, the information is also insufﬁcient. Although
PC has been shown to be related to insulin resistance, this rela-
tionship does not suggest directly that FPG should be higher withFig. 2. Metabolic syndrome components and platelet counts.PC36. The reason is that the level of FPG is determined by insulin
resistance and secretion. Therefore, when only insulin resistance is
taken into consideration, one would expect to miss the signiﬁcant
correlation between PC and FPG. This ﬁnding is similar to the
results obtained by Soogarun et al, who have found that there is no
relationship between PC and FPG37. From the above evidence, we
suggest that whether BP or FPG is related to PC warrants further
investigation in different age or ethnic groups.
There were two limitations in our study. First, this was only
a cross-sectional study, which provides less information than
a longitudinal observation. Second, if we could have measured
plasma insulin level, we could have carried out homeostasis model
assessment. This is considered to be the core of MetS and could
have allowed us to learn more about the interaction between
insulin resistance and PC.
In conclusion, geriatric women with MetS had higher PC than
subjects without MetS. Among the ﬁve components, BMI and TG
were positively correlated with PC. There was a positive correlation
between PC and LDL-C but not HDL-C. The importance of both lipids
should be re-evaluated in the future in older women.
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